About Daye
Daye is a company based in London (United Kingdom) founded in 2018. It operates as a Direct-to-Consumer (D2C) and HealthTech. Daye has raised $19.16 million across 4 funding rounds from investors including Khosla Ventures, Salica Investments and MassMutual Ventures. The company has 17 employees as of December 31, 2021. Daye offers products and services including Organic Tampons, Microbiome Screen, Hormone Test, Gynae Health Consultation, and ProViotics.
- Headquarter London, United Kingdom
- Employees 17 as on 31 Dec, 2021
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Daye Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$19.16 M (USD)
in 4 rounds
-
Latest Funding Round
$575.7 K (USD), Series A
Nov 21, 2025
-
Investors
Khosla Ventures
& 19 more
-
Employee Count
17
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Daye
Daye offers a comprehensive portfolio of products and services, including Organic Tampons, Microbiome Screen, Hormone Test, Gynae Health Consultation, and ProViotics.
Sustainable tampons are provided for menstrual care needs.
Vaginal health is assessed through microbiome screening tests.
Hormonal balance is evaluated with personalized testing kits.
Expert consultations are offered for gynae health concerns.
Supplements are provided for gut and vaginal health.
People of Daye
Unlock access to complete
Funding Insights of Daye
Daye has successfully raised a total of $19.16M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $575.7 thousand completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Daye
Daye has secured backing from 20 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Khosla Ventures, Salica Investments and MassMutual Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate-backed venture capital fund
|
Locked | Locked | Locked | |
|
Investments are focused on health technology for global impact.
|
Locked | Locked | Locked | |
|
Investment services in finance, healthcare, sustainability, and productivity sectors.
|
Locked | Locked | Locked |
Investor details for Daye
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Daye
Investment portfolio details for Daye
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Daye
Detailed financials for Daye
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Daye Comparisons
Peer comparison for Daye
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Daye
Detailed competitors of Daye
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Daye
Complete news archive for Daye
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Daye
Daye was founded in 2018.
Daye is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Daye is a funded company, having raised a total of $19.16M across 4 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Daye is 17.
Daye is focused on providing sustainable period care products and innovative gynae health solutions. A range of organic tampons, CBD tampons, and hemp pads is offered alongside vaginal health screenings, hormonal tests, and microbiome supplements. Services include expert consultations for gynae health concerns and fertility insights. The company operates in the womens health sector, aiming to bridge the gender health gap through scientific innovation. Products and testing kits are distributed across multiple countries in Europe and the United States.
Daye offers Organic Tampons, Microbiome Screen, Hormone Test, Gynae Health Consultation, and ProViotics.
Daye has 20 investors. Key investors include Khosla Ventures, Salica Investments, MassMutual Ventures, CVCA, and Cross-Border Impact Ventures.
The valuation of Daye is $12.34M as of May 2019.